Small molecule activation by frustrated Lewis pairs.

A series of frustrated Lewis pairs (FLPs) based on the Lewis acids tris(perchloroaryl)borane (BAr(Cl)), and tris(2,2',2''-perfluorobiphenyl)borane (PBB) and trialkylphosphines were prepared; their ability to effect the heterolytic cleavage of dihydrogen, insert carbon dioxide into the borohydride, and reduce the resulting formatoborate to methanol were studied. Additionally, the insertion of CO(2) into a B-OH bond is explored with the ultimate aim of developing a homogeneous, catalytic preparation of carbonates. The compound [PBB-OH][H-P((t)Bu)(3)] was characterised by single crystal X-ray crystallography.

Synthesis and characterisation of the ethylene bridged permethylindenyl cerium complex [(EBI*)CeI(THF)].

Synthesis, magnetic properties, NMR spectroscopy, and crystallographic details of an ethylene bridged hexamethylindenyl (EBI*) cerium iodide complex [(EBI*)CeI(THF)] are reported.

Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF.

BACKGROUND: While idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung disease, the aetiology of IPF is poorly understood. Familial cases of pulmonary fibrosis suggest a genetic basis for some forms of the disease. Recent reports have linked genetic mutations in surfactant protein C (SFTPC) with familial forms of pulmonary fibrosis, including one large family in which a number of family members were diagnosed with usual interstitial pneumonitis (UIP), the pathological correlate to IPF. Because of this finding in familial cases of pulmonary fibrosis, we searched for SFTPC mutations in a cohort of sporadic cases of UIP and non-specific interstitial pneumonitis (NSIP). METHODS: The gene for SFTPC was sequenced in 89 patients diagnosed with UIP, 46 patients with NSIP, and 104 normal controls. RESULTS: Ten single nucleotide polymorphisms in the SFTPC sequence were found in IPF patients and not in controls. Only one of these created an exonic change resulting in a change in amino acid sequence. In this case, a T to C substitution resulted in a change in amino acid 73 of the precursor protein from isoleucine to threonine. Of the remaining polymorphisms, one was in the 5' UTR, two were exonic without predicted amino acid sequence changes, and six were intronic. One intronic mutation suggested a potential enhancement of a splicing site. CONCLUSIONS: Mutations in SFTPC are identified infrequently in this patient population. These findings indicate that SFTPC mutations do not contribute to the pathogenesis of IPF in the majority of sporadic cases.

Genetics of primary pulmonary hypertension.

Familial primary pulmonary hypertension (FPPH) is a well described clinical entity in which the disease occurs in at least two first degree relatives. It is clinically and pathologically indistinguishable from sporadic PPH. Mutations in the gene which encodes bone morphogenetic receptor 2 have recently been discovered in familial and sporadic PPH. This review discusses the basic clinical and genetic features of FPPH, and describes the research that led to the discovery of the disease-causing gene. Potential mechanisms of disease are also discussed, as well as implications for future investigations.